Cancer Research UK logo.
SearchDonate
  • Search

A study of blinatumomab after chemotherapy for newly diagnosed diffuse B cell lymphoma

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This study is for people who have a high risk of their cancer coming back after chemotherapy.

Recruitment start: 15 February 2017

Recruitment end: 18 May 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Nick Morley

Supported by

Amgen

Last reviewed: 08 Jul 2018

CRUK internal database number: 14673

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.